Grifols SA (GIFOF)
GIFOF is quoted over the counter, not listed on an exchange. Grifols SA files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | GIFOF, quoted over the counter |
| SEC CIK | 0001438569 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | New York, NY |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-04-17 |
| Cash and burn | 825.0M EUR cash; operating cash flow 261.8M EUR a quarter. | Report 2025-12-31 |
| Shares outstanding | No cover-page share count in XBRL | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte Auditores, S.L., Barcelona, Spain | PCAOB Form AP 2026-05-21 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | 7.5B EUR | 402.0M EUR | 1.0B EUR | 825.0M EUR | 160K EUR | 7.5B EUR | 20-F 2026-04-17 |
| FY 2024 2024-12-31 | 7.2B EUR | 156.9M EUR | 902.2M EUR | 979.8M EUR | 318.2M EUR | 7.2B EUR | 20-F 2025-04-11 |
| FY 2023 2023-12-31 | 6.6B EUR | 42.3M EUR | 218.7M EUR | 529.6M EUR | 674.3M EUR | 6.6B EUR | 20-F 2025-04-11 |
| FY 2022 2022-12-31 | 6.1B EUR | 185.0M EUR | -1.4M EUR | 549.2M EUR | 449.4M EUR | 6.1B EUR | 20-F 2025-04-11 |
| FY 2021 2021-12-31 | 4.9B EUR | 188.7M EUR | 597.0M EUR | 2.7B EUR | 330.0M EUR | 4.9B EUR | 20-F 2024-04-19 |
| FY 2020 2020-12-31 | 5.3B EUR | 618.5M EUR | 1.1B EUR | 579.6M EUR | 169.6M EUR | 5.3B EUR | 20-F 2023-04-18 |
| FY 2019 2019-12-31 | 5.1B EUR | 625.1M EUR | 568.9M EUR | 742.0M EUR | 186.0M EUR | 5.1B EUR | 20-F 2022-04-29 |
| FY 2018 2018-12-31 | 4.5B EUR | 596.6M EUR | 737.4M EUR | 1.0B EUR | 154.8M EUR | 4.5B EUR | 20-F 2021-04-09 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2015-04-23 |
| Latest annual report | 20-F | 2026-04-17 |
| Latest quarterly / interim | 6-K | 2026-11-02 |
Source: SEC EDGAR submissions feed, 463 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier